Ixekizumab Improves Patient-Reported Outcomes through 52 Weeks in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to Tumor Necrosis Factor-Inhibitors Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kavanaugh, Arthur
  • Marzo-Ortega, Helena
  • Vender, Ronald
  • Birt, Julie
  • Adams, David
  • Benichou, Olivier
  • Lin, Chen-Yen
  • Nash, Peter

publication date

  • October 1, 2017